Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic
Background: The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/22400/2/22400.pdf |
| _version_ | 1824416511750569984 |
|---|---|
| author | Tanno, Luciana Kase Demoly, Pascal Martin, Bryan Berstein, Jonathan Morais Almeida, Mario Levin, Michael Fiocchi, Alessandro Sánchez Borges, Mario Caraballo, Luis R. Wong, Gary W.K. Ortega Martell, José Antonio Rouadi, Philip W. Yáñez, Anahí Wang, Liang Lu Peden, David B. Chikhladze, Manana González Díaz, Sandra Nora Fontaine, Jean-François Sublett, James L. Chang, Yoon-Seok Passalacqua, Giovanni Ansotegui, Ignacio J. Ebisawa, Motohiro Senna, Gianenrico Caminati, Marco |
| author_facet | Tanno, Luciana Kase Demoly, Pascal Martin, Bryan Berstein, Jonathan Morais Almeida, Mario Levin, Michael Fiocchi, Alessandro Sánchez Borges, Mario Caraballo, Luis R. Wong, Gary W.K. Ortega Martell, José Antonio Rouadi, Philip W. Yáñez, Anahí Wang, Liang Lu Peden, David B. Chikhladze, Manana González Díaz, Sandra Nora Fontaine, Jean-François Sublett, James L. Chang, Yoon-Seok Passalacqua, Giovanni Ansotegui, Ignacio J. Ebisawa, Motohiro Senna, Gianenrico Caminati, Marco |
| author_sort | Tanno, Luciana Kase |
| collection | Repositorio Institucional |
| description | Background: The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far have provided real-life data from the allergy community concerning allergy practice during the COVID-19 outbreak. Therefore, we proposed an international survey on the management of allergic patients during the current pandemic.
Methods: We performed an online survey undertaken to reach out the worldwide allergy community by e-mail and social media. The web-based questionnaire contained 24 questions covering demographic data from the participants, clinical practice during this period, and questions related to the new international classification and coding tools addressed for COVID-19. It was circulated for 8 weeks and had anonymous and volunteer context.
Results: Data are presented for 635 participants from 78 countries of all continents. Allergists with long-term professional experience were the main audience. As expected, we received many responses as “I have no data” or “I don’t know” to the questions of the survey. However, most with more experience on managing allergic patients during the pandemic agreed that patients suffering from allergic or hypersensitivity conditions have no increased risk of contracting COVID19 or developing SARS CoV-2. Also, participants mentioned that none of the allergy treatments (inhaled corticosteroids, allergen immunotherapy, biological agents) increased the risk of contracting COVID-19 infection including severe presentations.
Conclusion: The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specific treatments and vaccines are being explored. The information here presented intends to be helpful to the community but represents a course of action in a highly specific situation due to the state of emergency, and it should be helpful to health systems. |
| format | Article |
| id | eprints-22400 |
| institution | UANL |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | eprints |
| spelling | eprints-224002024-03-06T18:05:52Z http://eprints.uanl.mx/22400/ Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic Tanno, Luciana Kase Demoly, Pascal Martin, Bryan Berstein, Jonathan Morais Almeida, Mario Levin, Michael Fiocchi, Alessandro Sánchez Borges, Mario Caraballo, Luis R. Wong, Gary W.K. Ortega Martell, José Antonio Rouadi, Philip W. Yáñez, Anahí Wang, Liang Lu Peden, David B. Chikhladze, Manana González Díaz, Sandra Nora Fontaine, Jean-François Sublett, James L. Chang, Yoon-Seok Passalacqua, Giovanni Ansotegui, Ignacio J. Ebisawa, Motohiro Senna, Gianenrico Caminati, Marco RA Aspectos Públicos de la Medicina Background: The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far have provided real-life data from the allergy community concerning allergy practice during the COVID-19 outbreak. Therefore, we proposed an international survey on the management of allergic patients during the current pandemic. Methods: We performed an online survey undertaken to reach out the worldwide allergy community by e-mail and social media. The web-based questionnaire contained 24 questions covering demographic data from the participants, clinical practice during this period, and questions related to the new international classification and coding tools addressed for COVID-19. It was circulated for 8 weeks and had anonymous and volunteer context. Results: Data are presented for 635 participants from 78 countries of all continents. Allergists with long-term professional experience were the main audience. As expected, we received many responses as “I have no data” or “I don’t know” to the questions of the survey. However, most with more experience on managing allergic patients during the pandemic agreed that patients suffering from allergic or hypersensitivity conditions have no increased risk of contracting COVID19 or developing SARS CoV-2. Also, participants mentioned that none of the allergy treatments (inhaled corticosteroids, allergen immunotherapy, biological agents) increased the risk of contracting COVID-19 infection including severe presentations. Conclusion: The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specific treatments and vaccines are being explored. The information here presented intends to be helpful to the community but represents a course of action in a highly specific situation due to the state of emergency, and it should be helpful to health systems. Lippincott Williams & Wilkins 2021 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/22400/2/22400.pdf http://eprints.uanl.mx/22400/2.haspreviewThumbnailVersion/22400.pdf Tanno, Luciana Kase y Demoly, Pascal y Martin, Bryan y Berstein, Jonathan y Morais Almeida, Mario y Levin, Michael y Fiocchi, Alessandro y Sánchez Borges, Mario y Caraballo, Luis R. y Wong, Gary W.K. y Ortega Martell, José Antonio y Rouadi, Philip W. y Yáñez, Anahí y Wang, Liang Lu y Peden, David B. y Chikhladze, Manana y González Díaz, Sandra Nora y Fontaine, Jean-François y Sublett, James L. y Chang, Yoon-Seok y Passalacqua, Giovanni y Ansotegui, Ignacio J. y Ebisawa, Motohiro y Senna, Gianenrico y Caminati, Marco (2021) Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic. World Allergy Organization Journal, 14 (2). p. 100515. ISSN 19394551 http://doi.org/10.1016/j.waojou.2021.100515 doi:10.1016/j.waojou.2021.100515 |
| spellingShingle | RA Aspectos Públicos de la Medicina Tanno, Luciana Kase Demoly, Pascal Martin, Bryan Berstein, Jonathan Morais Almeida, Mario Levin, Michael Fiocchi, Alessandro Sánchez Borges, Mario Caraballo, Luis R. Wong, Gary W.K. Ortega Martell, José Antonio Rouadi, Philip W. Yáñez, Anahí Wang, Liang Lu Peden, David B. Chikhladze, Manana González Díaz, Sandra Nora Fontaine, Jean-François Sublett, James L. Chang, Yoon-Seok Passalacqua, Giovanni Ansotegui, Ignacio J. Ebisawa, Motohiro Senna, Gianenrico Caminati, Marco Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| title_full | Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| title_fullStr | Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| title_full_unstemmed | Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| title_short | Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic |
| title_sort | allergy and coronavirus disease covid 19 international survey real life data from the allergy community during the pandemic |
| topic | RA Aspectos Públicos de la Medicina |
| url | http://eprints.uanl.mx/22400/2/22400.pdf |
| work_keys_str_mv | AT tannolucianakase allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT demolypascal allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT martinbryan allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT bersteinjonathan allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT moraisalmeidamario allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT levinmichael allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT fiocchialessandro allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT sanchezborgesmario allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT caraballoluisr allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT wonggarywk allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT ortegamartelljoseantonio allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT rouadiphilipw allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT yanezanahi allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT wanglianglu allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT pedendavidb allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT chikhladzemanana allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT gonzalezdiazsandranora allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT fontainejeanfrancois allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT sublettjamesl allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT changyoonseok allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT passalacquagiovanni allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT ansoteguiignacioj allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT ebisawamotohiro allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT sennagianenrico allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic AT caminatimarco allergyandcoronavirusdiseasecovid19internationalsurveyreallifedatafromtheallergycommunityduringthepandemic |